Abstract
Purpose
The purpose of this study was to identify the frequency and possible cause of diffuse intrathoracic uptake on post-therapy I-131 scans in thyroid cancer patients.
Methods
We retrospectively reviewed 781 post-therapy scans of 755 thyroid cancer patients who underwent total thyroidectomy and radioactive iodine therapy between January and December 2010. Diffuse intrathoracic uptake on post-therapy scans was examined, and clinical patient characteristics including sex, age, regimen for thyroid-stimulating hormone (TSH) stimulation (thyroid hormone withdrawal or recombinant human TSH injection), TSH, thyroglobulin (Tg) and anti-thyroglobulin antibody (anti-Tg Ab) levels, therapeutic dose of radioactive iodine therapy and prior history of radioactive iodine therapy were recorded.Scan findings were correlated with chest CT, chest radiographs, laboratory tests and/or clinical status. Diffuse intrathoracic uptake without evidence of pathologic condition was categorized as indeterminate. The association between clinical characteristics and intrathoracic uptake were analyzed for negative intrathoracic uptake and indeterminate uptake groups.
Results
Diffuse intrathoracic uptake on post-therapy scans was demonstrated in 39 out of 755 (5.2 %) patients, among which 3 were confirmed as lung metastasis. The 14 patients that showed high Tg or anti-Tg Ab levels were considered to be at risk of having undetected micrometastasis on other imaging modalities. The remaining 22 were indeterminate (2.9 %).Upon comparison of negative intrathoracic uptake and indeterminate uptake groups, TSH stimulation by thyroid hormone withdrawal was shown to be significantly correlated with diffuse intrathoracic uptake (p < 0.05).
Conclusion
The frequency of diffuse intrathoracic uptake on post-therapy scans was 5.2 % and could be seen in thyroid cancer patients with underlying lung metastasis as well as those without definite pathologic condition. In the latter, there was a higher frequency for diffusely increased intrathoracic uptake in those who underwent thyroid hormone withdrawal rather than recombinant human TSH injection.
Similar content being viewed by others
References
Gultekin SS, Dilli A, Arikok AT, Bostanci H, Hasdemir AO. The false-positive radioiodine I-131 uptake in the foreign body granuloma located in gluteal adipose tissue. Radiol Oncol. 2012;46(1):28–31. doi:10.2478/v10019-011-0016-5.
Mitchell G, Pratt BE, Vini L, McCready VR, Harmer CL. False positive 131I whole body scans in thyroid cancer. Br J Radiol. 2000;73(870):627–35.
Nair N, Basu S, Pakhale H. Unusual uptake of radioiodine in the chest in a patient with thyroid carcinoma. Br J Radiol. 2004;77(913):63–7.
Yoon S, Hong I. Ovarian teratoma mimicking metastasis on I-131 scan: a case report. Nucl Med Mol Imaging. 2013;47(1):52–4. doi:10.1007/s13139-012-0167-3.
Lee EK, Kim KW, Park SY, Park YJ, Kim YT, Chung JK, et al. Mediastinal uptake misinterpreted as metastasis in papillary thyroid cancer. J Korean Endocr Soc. 2007;22(6):460–4.
Triggiani V, Moschetta M, Giagulli VA, Licchelli B, Guastamacchia E. Diffuse 131I lung uptake in bronchiectasis: a potential pitfall in the follow-up of differentiated thyroid carcinoma. Thyroid Off J Am Thyroid Assoc. 2012;22(12):1287–90. doi:10.1089/thy.2011.0439.
Luster M, Lippi F, Jarzab B, Perros P, Lassmann M, Reiners C, et al. rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review. Endocr-Relat Cancer. 2005;12(1):49–64. doi:10.1677/erc.1.00830.
Mazzaferri EL, Kloos RT. Using recombinant human TSH in the management of well-differentiated thyroid cancer: current strategies and future directions. Thyroid Off J Am Thyroid Assoc. 2000;10(9):767–78.
Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid Off J Am Thyroid Assoc. 2009;19(11):1167–214. doi:10.1089/thy.2009.0110.
Han JM, Kim WB, Yim JH, Kim WG, Kim TY, Ryu JS, et al. Long-term clinical outcome of differentiated thyroid cancer patients with undetectable stimulated thyroglobulin level one year after initial treatment. Thyroid Off J Am Thyroid Assoc. 2012;22(8):784–90. doi:10.1089/thy.2011.0322.
Cho SW, Choi H, Yeom GJ, Lim JA, Moon JH, Park DJ, et al. Long-term prognosis of differentiated thyroid cancer with lung metastasis in Korea and its prognostic factors. Thyroid Off J Am Thyroid Assoc. 2013. doi:10.1089/thy.2012.0654.
Lin JD, Chao TC, Chou SC, Hsueh C. Papillary thyroid carcinomas with lung metastases. Thyroid Off J Am Thyroid Assoc. 2004;14(12):1091–6. doi:10.1089/thy.2004.14.1091.
Ilgan S, Karacalioglu AO, Pabuscu Y, Atac GK, Arslan N, Ozturk E, et al. Iodine-131 treatment and high-resolution CT: results in patients with lung metastases from differentiated thyroid carcinoma. Eur J Nucl Med Mol Imaging. 2004;31(6):825–30. doi:10.1007/s00259-004-1460-x.
Ahn BC, Lee SW, Lee J, Kim C. Pulmonary aspergilloma mimicking metastasis from papillary thyroid cancer. Thyroid Off J Am Thyroid Assoc. 2011;21(5):555–8. doi:10.1089/thy.2010.0448.
Bakheet SM, Hammami MM, Powe J, Bazarbashi M, Al Suhaibani H. Radioiodine uptake in inactive pulmonary tuberculosis. Eur J Nucl Med. 1999;26(6):659–62.
Bakheet SM, Powe J, Hammami MM. Radioiodine uptake in the chest. J Nucl Med Off Publ Soc Nucl Med. 1997;38(6):984–6.
Maslack MM, Wilson CA. Iodine-131 accumulation in a pericardial effusion. J Nucl Med Off Publ Soc Nucl Med. 1987;28(1):133.
Ji JS, Chae HS, Cho YS, Kim HK, Kim SS, Kim CW, et al. Myxedema ascites: case report and literature review. J Korean Med Sci. 2006;21(4):761–4.
Mahajan SK, Machhan PC, Sood BR, Taneja S, Raina R, Thakur S, et al. Pitting oedema in hypothyroidism. J Assoc Physicians India. 2003;51:885.
Nascimento C, Bridji B, Dejax C, Schlumberger M, Leboulleux S. Thoracic 131I uptake after previous pneumonectomy in patients treated for differentiated thyroid cancer. Clin Nucl Med. 2012;37(6):587–90. doi:10.1097/RLU.0b013e3182485146.
Oh JR, Ahn BC. False-positive uptake on radioiodine whole-body scintigraphy: physiologic and pathologic variants unrelated to thyroid cancer. Am J Nucl Med Mol Imaging. 2012;2(3):362–85.
Soh EY, Duh QY, Sobhi SA, Young DM, Epstein HD, Wong MG, et al. Vascular endothelial growth factor expression is higher in differentiated thyroid cancer than in normal or benign thyroid. J Clin Endocrinol Metab. 1997;82(11):3741–7.
Hataya Y, Akamizu T, Kanamoto N, Moriyama K, Shimatsu A, Nakao K. A case of subclinical hypothyroidism developing marked pleural effusions and peripheral edema with elevated vascular endothelial growth factor. Endocr J. 2007;54(4):577–84.
Stathatos N, Wartofsky L. Perioperative management of patients with hypothyroidism. Endocr Metab Clin N Am. 2003;32(2):503–18.
Gottehrer A, Roa J, Stanford GG, Chernow B, Sahn SA. Hypothyroidism and pleural effusions. Chest. 1990;98(5):1130–2.
Carvalho MR, Ferreira TC, Leite V. Evaluation of whole-body retention of iodine-131 ((131)I) after postoperative remnant ablation for differentiated thyroid carcinoma—thyroxine withdrawal versus rhTSH administration: a retrospective comparison. Oncol Lett. 2012;3(3):617–20. doi:10.3892/ol.2011.523.
Zulewski H, Muller B, Exer P, Miserez AR, Staub JJ. Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. J Clin Endocrinol Metab. 1997;82(3):771–6.
Harun-Or-Rashid M, Asai M, Sun XY, Hayashi Y, Sakamoto J, Murata Y. Effect of thyroid statuses on sodium/iodide symporter (NIS) gene expression in the extrathyroidal tissues in mice. Thyroid Res. 2010;3(1):3. doi:10.1186/1756-6614-3-3.
Singh B, Bollmann R, Ahmadzadehfar H, Biersack HJ, Ezziddin S. Unusual case of well-differentiated papillary thyroid carcinoma lacking thyroglobulin expression while still concentrating radioiodine. Br J Radiol. 2006;79(945):e84–7. doi:10.1259/bjr/62250180.
Lee J, Soh EY. Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis clinical outcomes and prognostic factors. Ann Surg. 2010;251(1):114–9. doi:10.1097/SLA.0b013e3181b7faf6.
Shaha AR, Ferlito A, Rinaldo A. Distant metastases from thyroid and parathyroid cancer. ORL J Oto-rhino-laryngol Relat Spec. 2001;63(4):243–9.
Conflict of interest
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Choi, H.S., Kim, S.H., Park, S.Y. et al. Clinical Significance of Diffuse Intrathoracic Uptake on Post-Therapy I-131 Scans in Thyroid Cancer Patients. Nucl Med Mol Imaging 48, 63–71 (2014). https://doi.org/10.1007/s13139-013-0234-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13139-013-0234-4